Compare General Motors Company (GM) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Motors Company vs Humana Inc — how do they compare? General Motors Company trades at $77.19 (market cap $70.01B), while Humana Inc trades at $397.7 (market cap $48.96B). The key difference: General Motors Company is the larger of the two by market cap, and General Motors Company pays the higher dividend (0.93%). Which is the better fit depends on your goals.
| GM | HUM | |
|---|---|---|
Market Cap | $70.01B | $48.96B |
Sector | Consumer Cyclical | Health |
52-Week High | $86.38 | $409.42 |
52-Week Low | $48.89 | $163.67 |
Enterprise Value | $173.34B | $58.00B |
Dividend Yield | 0.93% | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Motors (GM) trades at $76.87, up 0.2% daily, with a neutral technical signal. The company shows strong operational cash flow of $26.87B in 2025 and has beaten earnings estimates for three consecutive quarters. Valuation metrics appear attractive with P/S of 0.4 and P/B of 1.12, while analyst consensus remains bullish with a $102 price target representing 33% upside potential.
GM presents a value opportunity with depressed valuation multiples despite recent earnings beats and solid cash generation. Key risks include declining profit margins (1.38% net margin in 2025), competitive pressures in the EV transition, and elevated debt levels. The stock's appeal hinges on margin stabilization and successful execution of strategic initiatives amid industry headwinds.
Humana (HUM) trades at $406.70, up 0.17% on the day, and is currently above its consensus price target. The stock shows a bullish technical signal with strong moving average support, though oscillators are neutral. Fundamentally, the company has beaten earnings expectations for three consecutive quarters and is executing a strategic shift from membership growth to profitability, targeting a 3% Medicare Advantage margin by 2028. Revenue has grown consistently from $92.9B in 2022 to $129.7B in 2025.
The outlook is mixed. The company's strategic pivot and recent contract wins like the Illinois Medicaid contract present growth opportunities. However, significant risks include multiple legal investigations into statements on healthcare costs, declining net profit margins (from 3.02% in 2022 to 0.91% in 2025), and a high P/E ratio of 43.52. Analyst sentiment is cautious, with a majority 'Hold' rating and a consensus price target 13% below the current price.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
